Argenx
ARGX
#456
Rank
โ‚น4.773 T
Marketcap
โ‚น77,135
Share price
-0.85%
Change (1 day)
35.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น814.03. In 2024 the company made an earnings per share (EPS) of โ‚น1,277 an increase over its 2023 EPS that were of -โ‚น473.55.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-39.2%
2024โ‚น1,277-369.77%
2023-โ‚น473.55-60.46%
2022-โ‚น1,19863.33%
2021-โ‚น733.27-40.37%
2020-โ‚น1,230183.47%
2019-โ‚น433.82123.09%
2018-โ‚น194.4654.93%
2017-โ‚น125.5114.07%
2016-โ‚น110.0313.05%
2015-โ‚น97.33-36.34%
2014-โ‚น152.89209.04%
2013-โ‚น49.47-33.99%
2012-โ‚น74.95185.59%
2011-โ‚น26.24